Advances in functional lipid nanoparticles: from drug delivery platforms to clinical applications-Reference-Cited by-同舟云学术

Advances in functional lipid nanoparticles: from drug delivery platforms to clinical applications

Published:2024-01-29 Issue:2 Volume:14 Page:
ISSN:2190-572X
Container-title:3 Biotech
language:en
Short-container-title:3 Biotech

Author:

Dhayalan Manikandan,Wang Wei,Riyaz S. U. Mohammed,Dinesh Rakshi Anuja,Shanmugam Jayashree,Irudayaraj Santiagu Stephen,Stalin Antony,Giri Jayant,Mallik Saurav^ORCID,Hu Ruifeng

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13205-023-03901-8.pdf

Reference221 articles.

1. Abina SHB, Kalle CV, Schmidt M, Cormack MPM, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, Basile GDS, Alexander I, Wintergerst U, Frebourg T, Aurias A, Lyonnet DS, Romana S, Weiss IR, Gross F, Valensi F, Delabesse E, Macintyre E, Sigaux F, Soulier J, Leiva LE, Wissler M, Prinz C, Rabbitts TH, Deist FL, Fischer A, Calvo MC (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for. SCID-X1. Science 302:1181–1185

2. Accardo A, Mansi R, Morisco A, Mangiapia G, Paduano L, Tesauro D, Radulescu A, Aurilio M, Aloj L, Arra C, Morelli G (2010) Peptide modified nanocarriers for selective targeting of bombesin receptors. Mol Biosyst 6:878–887

3. Adedoyin A, Bernardo JF, Swenson CE, Bolsack LE, Horwith G, DeWit S, Kelly E, Klasterksy J, Sculier JP, DeValeriola D, Anaissie E, Berestein GL, Cuentas AL (1997) Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies. Antimicrob Agents Chemother 41(10):2201–2208

4. Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, Samiei M, Kouhi M, Nejati-Koshki K (2013) Liposome: classification, preparation, and applications. Nanoscale Res Lett 8:102

5. Akinc A, Querbes W, De S, Qin J, Frank-Kamenetsky M, Jayaprakash KN, Jayaraman M, Rajeev KG, Cantley WL, Dorkin JR, Butler JS, Qin L, Racie T, Sprague A, Fava E, Zeigerer A, Hope MJ, Zerial M, Sah DW, Fitzgerald K, Tracy MA, Manoharan M, Koteliansky V, Fougerolles A, Maier MA (2010) Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Mol Ther 18:1357–1364

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioavailability of Liposomal Vitamin C in Powder Form: A Randomized, Double-Blind, Cross-Over Trial;Applied Sciences;2024-09-01

2. Nanomedicine in Neuroprotection, Neuroregeneration, and Blood–Brain Barrier Modulation: A Narrative Review;Medicina;2024-08-24

3. Lecithin Derived Nano-Propyl Gallate as Non-Toxic Anti-Inflammatory Agent: Synthesis, In-Vitro and In-Vivo Investigations;Journal of Cluster Science;2024-05-18

4. NET-targeted nanoparticles for antithrombotic therapy in pregnancy;iScience;2024-05

5. Microfluidic Manufacturing of Liposomes;AAPS Introductions in the Pharmaceutical Sciences;2024